Akorn Pharmaceutical Recall

May 16, 2023 | Optometry HQ Announcements

Akorn Operating Company LLC has ceased and shutdown all operations due to bankruptcy. The Akorn Trustee is initiating a voluntary recall of various within-expiry human and animal products as a result of the closures and discontinuation of the Quality activities.

• Per manufacturer: “The discontinuation of the Quality program would result in the company’s inability to assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess which render the products adulterated.”

• According to the manufacturer, ”further distribution or use of any remaining product on the market should cease immediately.



FDA Alert: Akorn Issues Voluntary Nationwide Recall of Various Human and Animal Drug Products Within Expiry Due to Company Shutdown (

FOR IMMEDIATE RELEASE – April 26, 2023 – Gurnee, IL, Akorn Operating Company LLC has filed Chapter 7 bankruptcy on February 23, 2023. In connection with that filing, the company has ceased and shutdown all operations and terminated all its employees of all domestic US Sites.

Akorn Multiple Products Recall _National PBM Patient-Level Recall Communication_FINAL_050923